Treatment of lung cancer

N Engl J Med. 2009 Dec 17;361(25):2485; author reply 2486-7. doi: 10.1056/NEJMc0909634.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / therapeutic use*
  • Disease-Free Survival
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Mutation
  • Paclitaxel / therapeutic use*
  • Proportional Hazards Models
  • Quinazolines / therapeutic use*
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Carboplatin
  • ErbB Receptors
  • Paclitaxel
  • Gefitinib